NLSUI OPAC header image

Competition issues in the pharmaceutical sector and right to access to medicine (Record no. 217036)

MARC details
000 -LEADER
fixed length control field 01874nam a2200145Ia 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20260209120130.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 260209s9999||||xx |||||||||||||| ||und||
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Priya Vijay
245 #0 - TITLE STATEMENT
Title Competition issues in the pharmaceutical sector and right to access to medicine
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. BangaloreBangalore
Name of publisher, distributor, etc. NLSIU
Date of publication, distribution, etc. 2012
300 ## - PHYSICAL DESCRIPTION
Extent 114 p. ; 25 cm.
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Table of Contents Backdrop of the study; Chapter One ; Pharmaceutical sector and Competition: different aspects ; History of pharmaceutical sector in India; II) Why to be regulated; II. Competition in Pharma sector and poverty and role of government; Advantages of Competition regime; Object of regulatory Control; Drug pricing & Competition; Chapter Two ; Regulatory Framework of the Pharmaceutical Sector ; Relevant legislations Rules ; Some Relevant policies ; Regulatory agencies ; Chapter Three ; Competition Issues in Pharmaceutical sector ; STATUTORY PROVISIONS: Anti-competitive agreements and collusive practices ; Cartel- ; Abuse of dominance ; Regulation of Combination; Chapter Four ; Merger & Acquisitions of Pharm a Companies ; Incentives for Mergers and Acquisitions by Indian companies ; Sun Pharmaceuticals Industries/Taro Pharmaceutical Industries ; Mylan Laboratories/E. Merck OHG ; Case 2- Daiichi-Ranbaxy Acquisition Deal; Piramal Bought by Abbot Laboratories; Acquisition of Dabur Pharma Fresenus Kabi ; Shantha Biotech acquired; Chapter Five ; ..,/issues relating to patenting and compulsory licencing; Chapter Six; Right to access to medicine and pricing issues of Drug; Suggestions that can help to have better access to medicine; Price regulation of Drugs; The genericmedicine pricing & Competition ; Pricing of Vaccines ; Conclusion; Bibliography.
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Dr. Sairam Bhat - GuideDr. Sairam Bhat - Guide
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://dans.nls.ac.in/handle/123456789/1951">https://dans.nls.ac.in/handle/123456789/1951</a>
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Date acquired Total Checkouts Barcode Date last seen Price effective from Koha item type
        . . 09.02.2026   LLM401 09.02.2026 09.02.2026 Dissertation